Alcohol detox for Lantana — CIWA-Ar-guided, medically supervised, discretion assured.

RECO Island is the closest small-census, physician-led alcohol detox to Lantana — 18 minutes south down Federal Highway from Old Town Lantana and Hypoluxo Island. Detox is CIWA-Ar-guided with symptom-triggered benzodiazepine dosing, 24/7 nursing, and standing thiamine, folate, and magnesium replacement from admission. Patients transition directly to residential treatment on the same campus with no waitlist and no third-party handoff, and MAT decisions — naltrexone, Vivitrol, acamprosate — are made during the detox stay rather than deferred.

Lantana and Hypoluxo Island occupy a narrow stretch of coast between Delray Beach and West Palm — close enough to the ocean that most residents can hear it, close enough to RECO Island’s Delray Beach campus that a 4 a.m. admission for alcohol withdrawal is an 18-minute drive down Federal Highway or a slightly shorter run along A1A. For the households scattered across Old Town Lantana, Manalapan, and Ocean Ridge, the practical question when a family member’s drinking has escalated to daily, quantity-heavy, morning-shakes territory is not whether to seek treatment — it is where the nearest physician-led medical detox with in-house residential continuity actually sits. RECO Island’s alcohol detox program is the closest small-census, CIWA-Ar-guided inpatient withdrawal service north of the Broward line.

Alcohol withdrawal is the one that can kill you

Opioid withdrawal is miserable but not lethal in an otherwise healthy adult. Stimulant withdrawal produces depression and hypersomnia. Alcohol withdrawal is categorically different: it carries genuine mortality, driven by generalized tonic-clonic seizures, delirium tremens, and the cardiovascular strain of adrenergic surge in patients often already burdened with hypertension, cardiomyopathy, or electrolyte derangement. Untreated severe withdrawal historically carries a mortality rate in the low single digits, and DTs alone still kill roughly one to four percent of patients even in supervised medical settings.

Risk stratification at intake identifies who needs the most aggressive management. The strongest single predictor of severe withdrawal is a prior history of withdrawal seizures or DTs. Others include daily consumption above roughly ten standard drinks, use duration measured in years rather than months, age over 60, coexisting benzodiazepine or GHB use, and comorbidities such as cirrhosis, pancreatitis, or coronary disease. RECO Island’s admitting physician documents each of these on arrival and adjusts nursing acuity, monitoring intervals, and pharmacologic strategy accordingly.

This is the reason medical detox is the standard of care for alcohol use disorder — not a preference, not an upgrade, not a marketing category. Attempting to taper alcohol at home with the encouragement of a well-meaning family member is a maneuver that produces avoidable deaths every year in South Florida.

CIWA-Ar and symptom-triggered benzodiazepine dosing

The Clinical Institute Withdrawal Assessment for Alcohol, revised — CIWA-Ar — is the ten-domain scoring instrument that structures every alcohol detox admission at RECO Island. Nursing scores nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation. Scores are assessed at defined intervals — every one to two hours during the acute window, extending to four-hour intervals as the patient stabilizes.

Benzodiazepines are administered when the score crosses a treatment threshold, not on a fixed schedule. Symptom-triggered dosing consistently outperforms fixed-schedule protocols across every endpoint that matters: total benzodiazepine load, length of stay, incidence of oversedation, and progression to complicated withdrawal. Agent selection depends on the clinical picture. Chlordiazepoxide and diazepam, with their long half-lives and active metabolites, produce a self-tapering effect useful in healthy adults. Lorazepam, cleared by glucuronidation rather than oxidative metabolism, is the appropriate choice for patients with cirrhosis, advanced age, or hepatic compromise.

Phenobarbital-based protocols and adjunctive gabapentin are available for the subset of patients who present with benzodiazepine tolerance or refractory withdrawal. The point is not that one drug is universally right — the point is that a physician chooses the agent for the patient rather than defaulting to a single protocol.

Thiamine, folate, and Wernicke prevention

Chronic heavy alcohol use produces thiamine deficiency through a combination of poor dietary intake, impaired intestinal absorption, and reduced hepatic storage. Wernicke’s encephalopathy — the classical triad of ophthalmoplegia, ataxia, and confusion — is the acute neurologic consequence; untreated, it progresses to the anterograde amnesia and confabulation of Korsakoff’s syndrome, which does not reverse.

Every alcohol detox admission at RECO Island receives parenteral thiamine — typically 100 mg IM or IV on day one, continued daily through the acute phase — before any carbohydrate load. Folate, a multivitamin, and magnesium replacement are added on the same day. Magnesium in particular matters: hypomagnesemia lowers the seizure threshold, and repletion is a routine part of the admission order set rather than a reactive intervention.

None of this is optional or discretionary. Skipping thiamine to save a dose or delaying it until oral intake is tolerated is how patients acquire permanent neurologic injury during what should have been a routine detox.

MAT initiation during detox and the transition to residential

Detox alone does not treat alcohol use disorder. It produces a physiologically stable patient with an untreated primary illness. RECO Island’s model is direct, same-campus transition from detox to residential treatment — no discharge to an unfamiliar facility, no waitlist, no third-party handoff — and medication-assisted treatment decisions are made during the detox stay so that the patient enters residential with a plan already in motion.

Oral naltrexone at 50 mg daily is often started once liver function tests confirm safety and the patient is at least seven to ten days opioid-free, which the detox window provides. Long-acting injectable naltrexone (Vivitrol, 380 mg IM monthly) is the preferred formulation for patients whose adherence to daily dosing is a realistic concern. Acamprosate at 666 mg three times daily is added or substituted when abstinence has been stabilized, typically at the residential transition point. Disulfiram remains an option for a specific, motivated subset of patients who want an aversive backstop and have the medical clearance for it.

Alongside pharmacotherapy, the residential program applies CBT for relapse prevention, motivational interviewing, DBT skills for emotion regulation, and EMDR where trauma is a clear driver of use. ASAM Criteria dimensions structure the ongoing level-of-care decisions, and PHQ-9 and GAD-7 track the depression and anxiety that so often unmask themselves once the alcohol clears.

What to expect on your first visit

Admissions from Lantana typically arrive by private vehicle or by RECO’s transport service. The intake window is 24 hours a day. On arrival, the patient meets the admitting nurse for vitals, breath alcohol, and a focused history covering last drink, typical daily volume, prior withdrawal episodes, seizure history, and current medications. Bloodwork — CBC, CMP, magnesium, phosphorus, lipase, and hepatitis panel — is drawn concurrently.

The physician evaluation follows, usually within the first hour. Initial CIWA-Ar scoring begins immediately, and the first benzodiazepine dose, if indicated, is administered based on that score rather than on the calendar. Thiamine, folate, and magnesium orders are entered on the admission set. Family contact and consent for release of information are handled during this window so that clinical updates can flow appropriately once the patient is settled.

Insurance and admissions from Lantana

RECO Island is in-network or contracted with most major commercial carriers used by South Florida households, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. A verification-of-benefits call typically takes 15 to 30 minutes and can run in parallel with the drive down from Lantana; the admissions team confirms deductible status, coinsurance, and any prior authorization requirement before arrival so that financial questions do not delay clinical care.

• Drive time: 18 minutes from Old Town Lantana via Federal Highway.
• Access: 24-hour admissions; no waitlist for medically appropriate cases.
• Continuity: Same-campus transition from detox to residential.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.